C57BL/6JNifdc-Igs2tm1(ACTA1-iCre/ERT2)Bcgen/Bcgen • 113810
| Product name | B-ACTA1-iCreERT2 mice |
|---|---|
| Catalog number | 113810 |
| Strain name | C57BL/6JNifdc-Igs2tm1(ACTA1-iCre/ERT2)Bcgen/Bcgen |
| Strain background | C57BL/6JNifdc |
| NCBI gene ID | 11459 (Mouse) |
| Aliases | Acts; Acta-2; Actsk-1 |
Gene targeting strategy for B-ACTA1-iCreERT2 mice.
An icre/ERT2 sequence cassette was placed in the safe harbor sites Hipp11 under the control of the ACTA1 promoter. When B-ACTA1-iCreERT2 mice were crossed with a strain containing a loxP-site flanked sequence of interest, and induced with tamoxifen, Cre-mediated recombination will result in deletion of the floxed sequence in the muscle tissues of offspring.
Tamoxifen-Induced tdTomato Expression in B-ACTA1-iCreERT2/CAG-tdTomato cKI Mice. B-ACTA1-iCreERT2/CAG-tdTomato cKI mice (female, 14-week-old) were divided into two groups. G1 (n=1) received daily intraperitoneal (i.p.) vehicle injections for 5 days. G2 (n=5) received i.p. tamoxifen (1 mg/mouse) daily for 5 days. After a 7-day washout period, tissues were collected for IHC to detect tdTomato expression (HUABIO, HA500049). TdTomato can be detected in cardiac muscle, gastrointestinal smooth muscle, vascular smooth muscle, and skeletal muscle (gastrocnemius and soleus muscle), confirming tissue-specific expression driven by the ACTA1 promoter in B-ACTA1-iCreERT2/CAG-tdTomato cKI mice. Scale, 40x.